Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026)

Dr Reddys Laboratories (RDY) has reported Current Assets for 10 consecutive years, with $3.2 billion the latest figure, recorded in Q1 2026.

• Quarterly Current Assets rose 9.94% year-over-year to $3.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 billion (up 9.94% YoY) and the FY2026 annual result came in at $3.2 billion, up 9.94% from the prior year.
• Current Assets grew to $3.2 billion in Q1 2026 per RDY's latest filing, from $2.9 billion in the prior quarter.
• Over the last five years, Current Assets for RDY reached as high as $3.2 billion in Q1 2026 and fell as low as $2.4 billion in Q1 2022.
• A 5-year average of $2.8 billion and a median of $2.9 billion in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets climbed 18.25% — and 2025, when it declined 1.61%.
• Year by year, Current Assets stood at $2.4 billion in 2022, then climbed by 5.05% to $2.5 billion in 2023, then climbed by 18.19% to $3.0 billion in 2024, then fell by 1.61% to $2.9 billion in 2025, then increased by 9.94% to $3.2 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $3.2 billion, $2.9 billion, and $3.0 billion for Q1 2026, Q1 2025, and Q1 2024 respectively.